IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism-Reference-Cited by-同舟云学术

IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism

Published:2015-03-20 Issue:5 Volume:61 Page:1627-1642
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yamada Daisaku¹,Rizvi Sumera¹,Razumilava Nataliya¹,Bronk Steven F.¹,Davila Jaime I.²,Champion Mia D.³,Borad Mitesh J.⁴,Bezerra Jorge A.⁵,Chen Xin⁶,Gores Gregory J.¹

Affiliation:

1. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN

2. Department of Health Sciences Research; Mayo Clinic; Rochester MN

3. Department of Biomedical Statistics and Informatics; Mayo Clinic; Scottsdale Arizona

4. Division of Hematology/Oncology; Mayo Clinic; Scottsdale AZ

5. Division of Gastroenterology, Hepatology and Nutrition; Cincinnati Children's Hospital Medical Center; Cincinnati OH

6. Department of Bioengineering and Therapeutic Sciences; University of California; San Francisco CA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Reference32 articles.

1. Pathogenesis, diagnosis, and management of cholangiocarcinoma;Rizvi;Gastroenterology,2013

2. Risk factors for cholangiocarcinoma;Tyson;Hepatology,2011

3. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes;Sia;Gastroenterology,2013

4. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma;Sirica;Nat Rev Gastroenterol Hepatol,2012

5. Burden of digestive diseases in the United States;Everhart;Part III: Liver, biliary tract, and pancreas. Gastroenterology,2009

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma;Current Cancer Drug Targets;2024-11

2. Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma;Genomics;2024-09

3. Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma;Liver International;2024-08-20

4. The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma;Current Cancer Drug Targets;2024-07

5. Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis;Journal of Hepatology;2024-07